These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 2835347

  • 21. Evaluation of humoral immunity tests in FeLV infected cats.
    Charreyre CE, Pedersen N.
    Dev Biol Stand; 1990; 72():197-200. PubMed ID: 2178116
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy of a feline leukemia virus vaccine in a natural exposure challenge.
    Legendre AM, Mitchener KL, Potgieter LN.
    J Vet Intern Med; 1990; 4(2):92-8. PubMed ID: 2160531
    [Abstract] [Full Text] [Related]

  • 23. Humoral immune reactivity to feline leukemia virus and associated antigens in cats naturally infected with feline leukemia virus.
    Lutz H, Pedersen N, Higgins J, Hübscher U, Troy FA, Theilen GH.
    Cancer Res; 1980 Oct; 40(10):3642-51. PubMed ID: 6254637
    [No Abstract] [Full Text] [Related]

  • 24. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK, de Noronha F, Tusch C, Michalek MT, McLane MF.
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [Abstract] [Full Text] [Related]

  • 25. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K, Pfauth A, van Herwijnen R, Jarrett O, Meloen RH, Tomee C, Osterhaus AD.
    Vaccine; 1993 Dec; 11(9):946-56. PubMed ID: 7692683
    [Abstract] [Full Text] [Related]

  • 26. Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays.
    Hofmann-Lehmann R, Tandon R, Boretti FS, Meli ML, Willi B, Cattori V, Gomes-Keller MA, Ossent P, Golder MC, Flynn JN, Lutz H.
    Vaccine; 2006 Feb 20; 24(8):1087-94. PubMed ID: 16198454
    [Abstract] [Full Text] [Related]

  • 27. Comparative efficacy of three commercial feline leukemia virus vaccines against methylprednisolone acetate-augmented oronasal challenge exposure with virulent virus.
    Pedersen NC, Johnson L.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1453-5. PubMed ID: 1666102
    [Abstract] [Full Text] [Related]

  • 28. Feline oncornavirus-associated cell membrane antigen. III. Antibody titers in cats from leukemia cluster households.
    Essex M, Jakowski RM, Hardy WD, Cotter SM, Hess P, Sliski A.
    J Natl Cancer Inst; 1975 Mar 15; 54(3):637-41. PubMed ID: 164563
    [Abstract] [Full Text] [Related]

  • 29. Safety and efficacy studies of live- and killed-feline leukemia virus vaccines.
    Pedersen NC, Theilen GH, Werner LL.
    Am J Vet Res; 1979 Aug 15; 40(8):1120-6. PubMed ID: 230767
    [Abstract] [Full Text] [Related]

  • 30. Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E.
    Langhammer S, Hübner J, Kurth R, Denner J.
    Immunology; 2006 Feb 15; 117(2):229-37. PubMed ID: 16423059
    [Abstract] [Full Text] [Related]

  • 31. Feline oncornavirus-associated cell membrane antigen. IV. Antibody titers in cats with naturally occurring leukemia, lymphoma, and other diseases.
    Essex M, Cotter SM, Hardy WD, Hess P, Jarrett W, Jarrett O, Mackey L, Laird H, Perryman L, Olsen RG, Yohn DS.
    J Natl Cancer Inst; 1975 Aug 15; 55(2):463-7. PubMed ID: 169377
    [Abstract] [Full Text] [Related]

  • 32. Effect of diethylcarbamazine on serum antibody to feline oncornavirus-associated cell membrane antigen in feline leukemia virus cats.
    Kitchen LW, Cotter SM.
    J Clin Lab Immunol; 1988 Feb 15; 25(2):101-3. PubMed ID: 2836593
    [Abstract] [Full Text] [Related]

  • 33. Randomized blind trial of a commercial FeLV vaccine.
    Pollock RV, Scarlett JM.
    J Am Vet Med Assoc; 1990 Feb 15; 196(4):611-6. PubMed ID: 2154424
    [Abstract] [Full Text] [Related]

  • 34. Serologic evaluation of vaccinated American river otters.
    Hoover JP, Castro AE, Nieves MA.
    J Am Vet Med Assoc; 1985 Dec 01; 187(11):1162-5. PubMed ID: 3001000
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evaluation of efficacy and safety of an inactivated virus vaccine against feline leukemia virus infection.
    Hines DL, Cutting JA, Dietrich DL, Walsh JA.
    J Am Vet Med Assoc; 1991 Nov 15; 199(10):1428-30. PubMed ID: 1666097
    [Abstract] [Full Text] [Related]

  • 38. Effect of diethylcarbamazine on cats given feline leukaemia virus vaccine.
    Kitchen LW.
    Vaccine; 1987 Dec 15; 5(4):266-7. PubMed ID: 2829454
    [Abstract] [Full Text] [Related]

  • 39. Prevalence of disease in nonviremic cats previously exposed to feline leukemia virus.
    Swenson CL, Kociba GJ, Mathes LE, Hand PJ, Neer CA, Hayes KA, Olsen RG.
    J Am Vet Med Assoc; 1990 Apr 01; 196(7):1049-52. PubMed ID: 2158493
    [Abstract] [Full Text] [Related]

  • 40. Feline leukemia virus envelope protein expression encoded by a recombinant vaccinia virus: apparent lack of immunogenicity in vaccinated animals.
    Gilbert JH, Pedersen NC, Nunberg JH.
    Virus Res; 1987 Feb 01; 7(1):49-67. PubMed ID: 3031895
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.